BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mylan Inc. 

1500 Corporate Drive

Canonsburg  Pennsylvania  15317  U.S.A.
Phone: 724-514-1800 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Mylan Inc. (MYL) Completes Acquisition Of Abbott (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 2/27/2015 11:21:00 AM
Mylan Inc. (MYL) Signs Exclusive Agreement With Gilead (GILD) To Distribute Sovaldi And Harvoni In India 2/23/2015 7:04:35 AM
Mylan Inc. (MYL) Schedules Fourth Quarter And Year End 2014 Financial Results Conference Call And Live Webcast 2/9/2015 12:19:52 PM
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015 9:49:11 AM
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/2/2015 6:36:33 AM
Mylan Inc. (MYL), Theravance, Inc. (THRX) Partner Up for $265 Million COPD Pact 2/2/2015 6:13:41 AM
Mylan Inc. (MYL) Shareholders Overwhelmingly Approve Agreement Implementing Acquisition Of Abbott Laboratories (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 1/29/2015 10:36:40 AM
Mylan Inc. (MYL) Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. (GILD) To Include Investigational Pan-Genotypic Agent 1/26/2015 10:28:20 AM
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015 11:07:58 AM
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015 7:29:09 AM
12345678910...